Kelly: Democrats Making Prescription Drug Policy about Politics, Not People

Dec 12, 2019 Issues: Health Care

Washington, D.C. - Today, the U.S. House of Representatives passed H.R. 3, the so-called Lower Drug Costs Now Act of 2019. Representative Mike Kelly (R-Pa.) voted against the bill and issued the following statement:

"Congressional action to address the prescription drug affordability crisis should be about people, not politics. While Democrats may have scored a few cheap political points with their socialist base by passing H.R. 3, they did nothing to help Americans who increasingly struggle to afford their medications. This government price-fixing scheme would lead to the development of fewer new cures and reduce access to existing life-saving drugs. We should focus our efforts on policy that will work and can pass such as H.R. 19, a bipartisan alternative to H.R. 3 that won't threaten medical innovation."

Representative Kelly also spoke against H.R. 3 on the floor of the House during debate on the evening of December 11. Video below.

H.R. 3 is a Democrat messaging bill, not a serious effort to bring relief to Americans.

Representative Kelly believes Americans deserve better than political games, particularly on issues as important as lowering prescription drug prices. He is an original co-sponsor of H.R. 19, the Lower Costs, More Cures Act, a bipartisan package of proposals that has a realistic chance of becoming law with the support of House Democrats.